{"entity":{"id":"nct02802540","kind":"trial","name":"Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients","aka":[],"tldr":"A phase 2/3 trial of Nabilone in Non-small-cell lung cancer, run by Instituto Nacional de Cancerologia de Mexico, with a status the registry has not verified recently.","summary":"Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients is a phase 2/3 interventional study registered as NCT02802540 by Instituto Nacional de Cancerologia de Mexico, with 78 participants planned, started 2014-12 and due to reach its primary completion in 2017-07. Interventions recorded: Nabilone, Placebo. Conditions recorded: Non-Small Cell Lung Cancer, Anorexia, Cachexia, Weight Lose.\n\nLinked to the drug Nabilone because the registry names it among its interventions and Non-small-cell lung cancer among its conditions. Registry record only: no result has been read by an editor.","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT02802540","url":"https://clinicaltrials.gov/study/NCT02802540"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":["nabilone"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT02802540","phase":"2/3","setting":"Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Patients With Anorexia Associated With Advanced Lung Cancer: Randomized Double Blind Clinical Trial","sponsor":"Instituto Nacional de Cancerologia de Mexico","enrolled":78,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct02802540/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"drug":[{"id":"nabilone","kind":"drug","name":"Nabilone","route":"/drugs/nabilone/"}]}}